Aplastic Anemia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There are two types of aplastic anemia: congenital and acquired. The acquired form represents over 90% of cases and usually results from an autoimmune attack against hematopoietic stem cells. The most common clinical manifestations reflect the low blood counts and include dyspnea on exertion, fatigue, easy bruising, petechia, epistaxis, gingival bleeding, heavy menses, headaches, and fever. The primary diagnostic procedure, in addition to a complete blood count, leukocyte differential, and reticulocyte count is the bone marrow aspirate and biopsy. The clinical response of aplastic anemia to immunosuppressive therapy provides the first data suggesting that aplastic anemia is immune mediated. More recently, it has been shown that the bone marrow in aplastic anemia is infiltrated with lymphocytes that secrete Th1 cytokines. Skewing of the V? repertoires demonstrated by CDR3 spectratyping further suggests that this is an antigen-driven autoimmune disorder. Moreover, newer methodologies are beginning to allow the study of the rare target cell populations in aplastic anemia.

Original languageEnglish (US)
Title of host publicationThe Autoimmune Diseases
PublisherElsevier Inc.
Pages591-599
Number of pages9
ISBN (Print)9780125959612
DOIs
StatePublished - 2006

Fingerprint

Aplastic Anemia
Bone Marrow
Reticulocyte Count
Epistaxis
Purpura
Menstruation
Blood Cell Count
Health Services Needs and Demand
Immunosuppressive Agents
Hematopoietic Stem Cells
Leukocyte Count
Dyspnea
Fatigue
Headache
Fever
Lymphocytes
Hemorrhage
Cytokines
Biopsy
Antigens

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Cite this

Brodsky, R. A., & Jones, R. J. (2006). Aplastic Anemia. In The Autoimmune Diseases (pp. 591-599). Elsevier Inc.. https://doi.org/10.1016/B978-012595961-2/50047-0

Aplastic Anemia. / Brodsky, Robert A; Jones, Richard J.

The Autoimmune Diseases. Elsevier Inc., 2006. p. 591-599.

Research output: Chapter in Book/Report/Conference proceedingChapter

Brodsky, RA & Jones, RJ 2006, Aplastic Anemia. in The Autoimmune Diseases. Elsevier Inc., pp. 591-599. https://doi.org/10.1016/B978-012595961-2/50047-0
Brodsky RA, Jones RJ. Aplastic Anemia. In The Autoimmune Diseases. Elsevier Inc. 2006. p. 591-599 https://doi.org/10.1016/B978-012595961-2/50047-0
Brodsky, Robert A ; Jones, Richard J. / Aplastic Anemia. The Autoimmune Diseases. Elsevier Inc., 2006. pp. 591-599
@inbook{b51fae404de942f982b397e40c66d6d4,
title = "Aplastic Anemia",
abstract = "There are two types of aplastic anemia: congenital and acquired. The acquired form represents over 90{\%} of cases and usually results from an autoimmune attack against hematopoietic stem cells. The most common clinical manifestations reflect the low blood counts and include dyspnea on exertion, fatigue, easy bruising, petechia, epistaxis, gingival bleeding, heavy menses, headaches, and fever. The primary diagnostic procedure, in addition to a complete blood count, leukocyte differential, and reticulocyte count is the bone marrow aspirate and biopsy. The clinical response of aplastic anemia to immunosuppressive therapy provides the first data suggesting that aplastic anemia is immune mediated. More recently, it has been shown that the bone marrow in aplastic anemia is infiltrated with lymphocytes that secrete Th1 cytokines. Skewing of the V? repertoires demonstrated by CDR3 spectratyping further suggests that this is an antigen-driven autoimmune disorder. Moreover, newer methodologies are beginning to allow the study of the rare target cell populations in aplastic anemia.",
author = "Brodsky, {Robert A} and Jones, {Richard J}",
year = "2006",
doi = "10.1016/B978-012595961-2/50047-0",
language = "English (US)",
isbn = "9780125959612",
pages = "591--599",
booktitle = "The Autoimmune Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Aplastic Anemia

AU - Brodsky, Robert A

AU - Jones, Richard J

PY - 2006

Y1 - 2006

N2 - There are two types of aplastic anemia: congenital and acquired. The acquired form represents over 90% of cases and usually results from an autoimmune attack against hematopoietic stem cells. The most common clinical manifestations reflect the low blood counts and include dyspnea on exertion, fatigue, easy bruising, petechia, epistaxis, gingival bleeding, heavy menses, headaches, and fever. The primary diagnostic procedure, in addition to a complete blood count, leukocyte differential, and reticulocyte count is the bone marrow aspirate and biopsy. The clinical response of aplastic anemia to immunosuppressive therapy provides the first data suggesting that aplastic anemia is immune mediated. More recently, it has been shown that the bone marrow in aplastic anemia is infiltrated with lymphocytes that secrete Th1 cytokines. Skewing of the V? repertoires demonstrated by CDR3 spectratyping further suggests that this is an antigen-driven autoimmune disorder. Moreover, newer methodologies are beginning to allow the study of the rare target cell populations in aplastic anemia.

AB - There are two types of aplastic anemia: congenital and acquired. The acquired form represents over 90% of cases and usually results from an autoimmune attack against hematopoietic stem cells. The most common clinical manifestations reflect the low blood counts and include dyspnea on exertion, fatigue, easy bruising, petechia, epistaxis, gingival bleeding, heavy menses, headaches, and fever. The primary diagnostic procedure, in addition to a complete blood count, leukocyte differential, and reticulocyte count is the bone marrow aspirate and biopsy. The clinical response of aplastic anemia to immunosuppressive therapy provides the first data suggesting that aplastic anemia is immune mediated. More recently, it has been shown that the bone marrow in aplastic anemia is infiltrated with lymphocytes that secrete Th1 cytokines. Skewing of the V? repertoires demonstrated by CDR3 spectratyping further suggests that this is an antigen-driven autoimmune disorder. Moreover, newer methodologies are beginning to allow the study of the rare target cell populations in aplastic anemia.

UR - http://www.scopus.com/inward/record.url?scp=84882850013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882850013&partnerID=8YFLogxK

U2 - 10.1016/B978-012595961-2/50047-0

DO - 10.1016/B978-012595961-2/50047-0

M3 - Chapter

AN - SCOPUS:84882850013

SN - 9780125959612

SP - 591

EP - 599

BT - The Autoimmune Diseases

PB - Elsevier Inc.

ER -